Gold Nanoparticle-Based Hydrogel: Application in Anticancer Drug Delivery and Wound Healing In Vitro
Pharmaceutics · 09.05.2025 · 17 (5) · 633
DOI: 10.3390/pharmaceutics17050633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.05.2025. Verfasst von Varshan Gounden und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nano-Gene and Drug Delivery Laboratory, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Background/Objectives: Due to the challenges faced by anticancer therapeutics, such as poor selectivity and metabolic degradation, novel delivery systems are needed to mitigate the adverse effects of chemotherapy. The management of chronic wounds is often overlooked and affects patients mentally and physically. The application of hydrogels can reduce deficiencies in drug delivery and wound healing due to their similarity to the extracellular matrix and stimuli-responsive properties.
Methods
A chitosan (CS) hydrogel, cross-linked to gold nanoparticles (AuNPs), followed by the encapsulation of 5-fluorouracil (5-FU), was formulated. The physicochemical properties, drug release profiles, cytotoxicity, and wound healing in vitro were analyzed.
Results
Fourier transform infrared spectroscopy and a UV-visible peak at 530 nm confirmed their successful synthesis. Transmission electron microscopy revealed spherical NPs of 89.31 nm, while scanning electron microscopy confirmed the porous network surface of the hydrogels. The thermogravimetric analysis demonstrated enhanced stability for the CS-Au hydrogel, while a non-Newtonian shear-thinning property was evident from rheology. Drug release showed a sustained, pH-dependent release with specificity for the acidic cancer microenvironment. The cytotoxicity assay demonstrated a specificity of the CS-Au-5-FU hydrogel for the cancer cells (HeLa and MCF-7) and diminished cytotoxicity in the non-cancer cells (HEK293). The scratch assay illustrated a complete closure of the wounds in HEK293 cells at low concentrations (15.63 and 31.25 µg/mL).
Conclusions
The positive findings from this study confirm the potential of these CS-Au hydrogels to function as smart in vitro delivery systems and scaffolds for wound healing, warranting additional optimizations and in vivo studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nano-Gene and Drug Delivery Laboratory, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.
ORCID-Profile: Moganavelli Singh
Zitieren
APA
Gounden, V., & Singh, M. (2025). Gold Nanoparticle-Based Hydrogel: Application in Anticancer Drug Delivery and Wound Healing In Vitro. Pharmaceutics, 17(5), 633. https://doi.org/10.3390/pharmaceutics17050633
Vancouver
Gounden V, Singh M. Gold Nanoparticle-Based Hydrogel: Application in Anticancer Drug Delivery and Wound Healing In Vitro. Pharmaceutics. 2025;17(5):633. doi:10.3390/pharmaceutics17050633
BibTeX
@article{Gounden2025,
author = {Gounden, Varshan and Singh, Moganavelli},
title = {Gold Nanoparticle-Based Hydrogel: Application in Anticancer Drug Delivery and Wound Healing In Vitro},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {5},
pages = {633},
doi = {10.3390/pharmaceutics17050633}
}
EUVIMED